deltatrials
Terminated PHASE1 INTERVENTIONAL 1-arm NCT05298358

RIC alloBMT With Post-transplant Cyclophosphamide for Refractory Systemic Sclerosis

A Phase I Study of Reduced Intensity Conditioning Allogeneic Bone Marrow Transplant With Post-transplant Cyclophosphamide for Refractory Systemic Sclerosis

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Conditions Systemic Sclerosis
Interventions RIC alloBMT w PTCy in refractory SSc
Updated 10 times since 2022 Last updated: Feb 3, 2025 Started: Nov 18, 2022 Primary completion: Nov 13, 2024 Completion: Nov 21, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

This study was closed due to low accrual

Other terminated trials from Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

See all terminations from Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

A PHASE1 clinical study on Systemic Sclerosis, this trial is terminated or withdrawn. The trial is conducted by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins and has accumulated 10 data snapshots since 2022. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Apr 2022 – ~Jul 2022 · 3 months · monthly snapshotNot Yet Recruiting~Jul 2022 – ~Sep 2022 · 2 months · monthly snapshotNot Yet Recruiting~Sep 2022 – ~Nov 2022 · 2 months · monthly snapshotNot Yet Recruiting~Nov 2022 – ~Dec 2022 · 30 days · monthly snapshotNot Yet Recruiting~Dec 2022 – ~Feb 2023 · 2 months · monthly snapshotNot Yet Recruiting~Feb 2023 – ~Jan 2024 · 11 months · monthly snapshotRecruiting~Jan 2024 – ~Jul 2024 · 6 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotRecruiting~Sep 2024 – ~Mar 2025 · 6 months · monthly snapshotRecruiting~Mar 2025 – present · 16 months · monthly snapshotTerminated

Change History

10 versions recorded

  1. Mar 2025 — Present [monthly]

    Terminated PHASE1

    Status: Recruiting → Terminated

  2. Sep 2024 — Mar 2025 [monthly]

    Recruiting PHASE1

  3. Jul 2024 — Sep 2024 [monthly]

    Recruiting PHASE1

  4. Jan 2024 — Jul 2024 [monthly]

    Recruiting PHASE1

  5. Feb 2023 — Jan 2024 [monthly]

    Recruiting PHASE1

    Status: Not Yet Recruiting → Recruiting

▶ Show 5 earlier versions

  1. Dec 2022 — Feb 2023 [monthly]

    Not Yet Recruiting PHASE1

  2. Nov 2022 — Dec 2022 [monthly]

    Not Yet Recruiting PHASE1

  3. Sep 2022 — Nov 2022 [monthly]

    Not Yet Recruiting PHASE1

  4. Jul 2022 — Sep 2022 [monthly]

    Not Yet Recruiting PHASE1

  5. Apr 2022 — Jul 2022 [monthly]

    Not Yet Recruiting PHASE1

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Data source: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations